Latest Recruitment News

Savannah Goldfields is advancing steadily towards resuming gold production at its Georgetown plant, with environmental approvals secured and operational preparations underway for an October restart.

Theta Gold Mines has officially begun construction at its flagship TGME Gold Mine in South Africa, securing key contracts and funding support that pave the way for production by early 2027.

Prophecy International Holdings Ltd has announced the immediate resignation of CEO Brad Thomas, with Chairman Ed Reynolds stepping in as acting CEO during the leadership transition.

Orthocell Limited reports an 81.1% overall treatment success rate from its Remplir Real World Evidence study, reinforcing the product’s safety and efficacy as it expands sales in the US and prepares regulatory submissions for the EU and UK.

Metallium Ltd has appointed former U.S. Deputy Assistant Secretary of Defense Travis Langster to its U.S. advisory board, aiming to strengthen ties with government and industry for critical metals supply chain resilience.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.

OpenLearning Limited reported a 30% revenue increase for the half-year to June 2025, driven by expanded AI-powered LMS adoption and multi-year contracts in the Philippines, while working towards break-even despite a wider loss.

BauMart Holdings Limited has dramatically reduced its net loss to just $123,086 in FY25, down from $4.68 million the previous year, amid a strategic pivot and successful capital raise.

BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.

Adherium Limited reported a $12.68 million net loss for FY2025 as it pivots towards commercialising its smart inhaler technology in the US, supported by a $4.49 million capital raise.

Nanollose Limited reported a $1.43 million loss for FY2025 while progressing pilot production of innovative biomaterials and strengthening its balance sheet with a $2.1 million capital raise. The company appointed a new CEO to drive commercialisation efforts in FY2026.